| Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin. | |
| | |
MedLine Citation:
|
PMID: 17414408 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Treatment options for primary cutaneous aspergillosis in neonates are limited by the lack of pharmacokinetic and safety data of newer antifungal agents that are effective against Aspergillus spp. We report the successful treatment of cutaneous aspergillosis in an extremely low-birth-weight preterm infant with liposomal amphotericin B, voriconazole and micafungin, and provide pharmacokinetic profiles for voriconazole and micafungin. |
| | |
Authors:
|
Roberto P Santos; Pablo J Sánchez; Asuncion Mejias; Daniel K Benjamin; Thomas J Walsh; Sanjay Patel; Hasan S Jafri |
Related Documents
:
|
19839958 - Management of isolated rectal bleeding in newborn infants: comparison of two time periods. 10530848 - The use of ultrasound in determining the initiation of treatment in instability of the ... 6244378 - The effect of acth therapy upon infantile spasms. 21145518 - Stretching treatment for infants with congenital muscular torticollis: physiotherapist ... 14599038 - Influence of different types of post-discharge feeding on somatic growth, cognitive dev... 20525358 - Predictors of positive blood culture and deaths among neonates with suspected neonatal ... |
Publication Detail:
|
Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural |
Journal Detail:
|
Title: The Pediatric infectious disease journal Volume: 26 ISSN: 0891-3668 ISO Abbreviation: Pediatr. Infect. Dis. J. Publication Date: 2007 Apr |
Date Detail:
|
Created Date: 2007-04-06 Completed Date: 2007-06-05 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 8701858 Medline TA: Pediatr Infect Dis J Country: United States |
Other Details:
|
Languages: eng Pagination: 364-6 Citation Subset: IM |
Affiliation:
|
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390-9063, USA. roberto.santos@UTSouthwestern.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amphotericin B
/
therapeutic use Antifungal Agents / therapeutic use* Aspergillosis / drug therapy*, microbiology Dermatomycoses / drug therapy*, microbiology Echinocandins Humans Infant, Extremely Low Birth Weight Infant, Newborn Infant, Premature Infant, Premature, Diseases / drug therapy*, microbiology Lipopeptides Lipoproteins / therapeutic use Peptides, Cyclic / therapeutic use Pyrimidines / therapeutic use Treatment Outcome Triazoles / therapeutic use |
| Grant Support | |
ID/Acronym/Agency:
|
1U10-HD45962-02/HD/NICHD NIH HHS; HD046000/HD/NICHD NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Antifungal Agents; 0/Echinocandins; 0/Lipopeptides; 0/Lipoproteins; 0/Peptides, Cyclic; 0/Pyrimidines; 0/Triazoles; 0/liposomal amphotericin B; 0/micafungin; 0/voriconazole; 1397-89-3/Amphotericin B |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effectiveness of early initiation of protease inhibitor-sparing antiretroviral regimen in human immu...
Next Document: A case of interleukin-12 receptor beta-1 deficiency with recurrent leishmaniasis.